{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-033282","form_type":"8-K","ticker":"BBIO","cik":"0001743881","company_name":"BridgeBio Pharma, Inc.","filed_at":"2026-08-17T13:05:22+00:00","discovered_at":"2026-08-17T13:06:00.247480+00:00","generated_at":"2026-08-17T13:06:17.217700+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BridgeBio secondary offering: KKR sells 5M shares at $78, no proceeds to company","bullets":["KKR Genetic Disorder L.P. selling 5,000,000 shares at $78.00/share; expected close Aug 17, 2026.","Company receives no proceeds; offering oversubscribed per Aug 14 press release.","Joint book-runners: William Blair, Goldman Sachs & Co. LLC, KKR Capital Markets LLC.","Offering launched Aug 13, priced Aug 14; aims to diversify shareholder base toward long-term ownership."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-033282","json":"https://secwatch.observer/filing/0001140361-26-033282.json","markdown":"https://secwatch.observer/filing/0001140361-26-033282.md","text":"https://secwatch.observer/filing/0001140361-26-033282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126033282/0001140361-26-033282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126033282/ef20080234_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T13:06:17.217700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}